Stock Detail
QUIDEL CORPORATION
Diagnostic Substances
QDEL @ Yahoo Finance | QDEL Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $16.88 | $17.49 | $-0.27 | -1.57% | 0.00 | $17.15 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $16.99 | $16.85 | 113,619 | 561.25M | 152,952.67 | 88.46 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 17.71 | 17.29 | 17.07 | 16.65 | 16.43 |
Stock Profile
Quidel Corporation engages in the development, manufacture, and marketing of point-of-care (POC) rapid diagnostic solutions for infectious diseases and reproductive health. Its POC and diagnostic tests include QuickVue, QuickVue+, QuickVue Advance, RapidVue, BlueTest, and Metra. These products provide diagnostic information for acute and chronic conditions that affect women and their family's health. The company offers POC diagnostics for infectious diseases, such as Influenza, Group A Strep, Helicobacter pylori, and Mononucleosis; Reproductive Health, which include Pregnancy, Chlamydia, and Bacterial Vaginosis; and Bone Health and Oncology. Quidel's products under development include Strep A web, respiratory syncitial virus test, LTF technology platforms, and QuickVue advance pH and amines test. The company incorporates immunoassay, enzymology, biochemistry, and microbiology technology into its diagnostic products. It markets its products to its customers through a network of distributors supported by a direct sales force in the United States, and through distributors and sales agents primarily in Japan, Europe, and Latin America. Quidel sells its products to professionals for use in physician offices, hospitals, clinical laboratories, and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, California.